ARCSA ARCSA-DE-2026-026-DASPARCSA-DE-2026-026-DASP
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
ARCSA-DE-2026-026-DASP is the official ARCSA identifier for “2026 Natural Medicinal Products Amendment with Express Medical Device Repeals — Complete Instrument in Gazette347 Excerpt”. ARCSA-DE-2026-026-DASP is the official identifier ARCSA uses for this instrument.
- Instrument
- ARCSA-DE-2026-026-DASP
- Full name
- ARCSA-DE-2026-026-DASP
- Category
- Registration
- Source publication
- Spanish
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
2026 Natural Medicinal Products Amendment with Express Medical Device Repeals — Complete Instrument in Gazette347 Excerpt
Complete38-page agency-hosted Gazette347 excerpt: original cover/sumario printed1–2 and the entire ARCSA-DE-2026-026-DASP instrument printed24–59(physical3–38). Cover identifies a71-page issue; this file is not the whole Gazette. The principal instrument amends natural medicinal products rules. Only express repeal provisions at physical37/printed58 identify medical-device ARCSA-DE-2026-003-DASP Article29(e) and Article51(a); natural-product provisions are not represented as MD/IVD requirements. Complete native text and all38 original page images, including the dated signature physical38/printed59, are retained. Adoption28July2026/publication14August2026 remain source evidence; no absolute effective date, current status, filing route, fee or question conclusion is inferred.
ARCSA-DE-2026-026-DASP is the official identifier ARCSA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.